FPN’s second annual Neuropathy Advocacy Day 

The Foundation for Peripheral Neuropathy (FPN) held our second annual Neuropathy Advocacy Day on March 11. It was an important day to speak up for the 30 million Americans living with peripheral neuropathy (PN). Together, we asked Congress to support more research and better care for people affected by this condition.  Goals of Advocacy Day  […]

Read More… from FPN’s second annual Neuropathy Advocacy Day 

Neuropathy News March 2026

neuropathy news image

Nominations Open: PRMRP Consumer Reviewer (Due March 17) The Congressionally Directed Medical Research Programs (CDMRP) is looking for new consumer reviewers to join upcoming scientific review panels. If you are a PN patient and want to review research grants, this opportunity is for you! This year, $370 million has been approved for the program. Peripheral […]

Read More… from Neuropathy News March 2026

Ariel Zhang, PhD, awarded scholarship for neuropathy research 

Ariel Zhang, PhD, was awarded one of two 2026 Clinical Research Training Scholarship (CRTS) to support her important research on chemotherapy-induced peripheral neuropathy (CIPN). The CRTS is a two-year scholarship program that provides funding for emerging experts in neuropathy. The scholarship supports researchers’ efforts to advance treatments, prevention, and even cures for peripheral neuropathy (PN) and is fully funded by the Foundation for Peripheral Neuropathy.  Zhang’s research  Even though CIPN is common, it has not been studied as much as […]

Read More… from Ariel Zhang, PhD, awarded scholarship for neuropathy research 

A Call to Action for Peripheral Neuropathy Research: NIH Collaboration, Funding Gaps, and the Future of PN Treatment

research scientists in lab

Peripheral Neuropathy Affects Millions Worldwide Peripheral neuropathy (PN) affects an estimated 30 million Americans and approximately 130 million people worldwide. There are dozens of causes, but metabolic disease — including obesity, pre-diabetes, and diabetes — is by far the leading driver of PN. Metabolic Disease as the Leading Cause of Peripheral Neuropathy Metabolic dysfunction plays […]

Read More… from A Call to Action for Peripheral Neuropathy Research: NIH Collaboration, Funding Gaps, and the Future of PN Treatment

Dr. Erika Williams shares findings from her Clinical Research Training Scholarship 

CRTS Updates.

Meet the researcher: 2023 CRTS recipient Dr. Erika Williams  Erika Williams, MD, PhD, a neuromuscular fellow at Massachusetts General Brigham, was one of our first Clinical Research Training Scholarship recipients in 2023.  Her research focused on the autonomic nervous system (ANS), a component of the peripheral nervous system.   “The Foundation for Peripheral Neuropathy‘s Clinical Research Training Scholarship made this work possible,” Williams shared. “The transition to an independent research career is a particularly vulnerable […]

Read More… from Dr. Erika Williams shares findings from her Clinical Research Training Scholarship 

Neuropathy News Feb. 2026

neuropathy news image

Critical funding restored for medical research  After a huge cut in 2025, research funding for the Department of Defense’s Peer Reviewed Medical Research Program is finally back to its earlier level: $370 million.   This is great news for people living with peripheral neuropathy. Each year, we work hard to make sure PN is one of the topics that can receive this funding. The more […]

Read More… from Neuropathy News Feb. 2026

Advocating for peripheral neuropathy: A conversation with FPN’s advocacy consultant, Mark Vieth   

Program Manager, Amanda Homscheid, recently sat down with Mark Vieth, our consultant who helps the Foundation for Peripheral Neuropathy advocate for neuropathy-related funding, such as the Peer Reviewed Medical Research Program (PRMRP), and connects us with important groups on Capitol Hill, like the National Institutes of Health (NIH).   Mark has been working with the Foundation for Peripheral Neuropathy for over 6 years. In this interview, he reflects on the accomplishments and progress we have made and his hopes and goals for the future.   Q. You’ve worked […]

Read More… from Advocating for peripheral neuropathy: A conversation with FPN’s advocacy consultant, Mark Vieth   

FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study 

The Foundation for Peripheral Neuropathy (FPN) is excited to share that the Brigham and Women’s Hospital has joined the IMAGiNe Study as a new research site. With help from FPN, they will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare autoimmune form of PN.  About the IMAGiNe Study  The IMAGiNe Study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical Center in the Netherlands. The study is creating a […]

Read More… from FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study 

Critical funding restored for medical research

Veteran-focused Peer Reviewed Medical Research Program funding returned to 2024 funding level after 50% cut in 2025  After a huge cut in 2025, research funding for the Department of Defense’s Peer Reviewed Medical Research Program (PRMRP) is finally back to its earlier level: $370 million. This is great news for people living with peripheral neuropathy (PN), because each year we work hard […]

Read More… from Critical funding restored for medical research

IMAGiNe study progress: 2025 highlights and what’s ahead

As we start a new year, we are excited to look back at what the IMAGiNe study achieved in 2025. We are also looking ahead to our goals for 2026 and beyond. At the Foundation for Peripheral Neuropathy (FPN), we celebrate every milestone that helps move peripheral neuropathy research forward.   About the IMAGiNe study  The IMAGiNe study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical […]

Read More… from IMAGiNe study progress: 2025 highlights and what’s ahead